HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of oral valaciclovir in a 12-year-old boy with herpes simplex encephalitis.

Abstract
We report on a 12-year-old boy with herpes simplex encephalitis, in whom a severe localised skin reaction developed following the infusion of intravenous acyclovir. Oral valaciclovir was given as continuation therapy to complete the 3-week course of antiviral treatment and resulted in complete recovery without side effects. This report illustrates the advantage of using the polymerase chain reaction to diagnose herpes simplex encephalitis and the potential use of newer antiviral agents, such as valaciclovir, as continuation therapy in the management of the infection. The higher oral bioavailability of newer antiviral agents allows part of the extended treatment period of patients with herpes simplex encephalitis to be carried out as an ambulatory oral regimen.
AuthorsP K Chan, P C Chow, J S Peiris, A W Mak, K F Huen
JournalHong Kong medical journal = Xianggang yi xue za zhi (Hong Kong Med J) Vol. 6 Issue 1 Pg. 119-21 (Mar 2000) ISSN: 1024-2708 [Print] China
PMID10793414 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiviral Agents
  • Prodrugs
  • Valine
  • Valacyclovir
  • Acyclovir
Topics
  • Acyclovir (analogs & derivatives, therapeutic use)
  • Antiviral Agents (therapeutic use)
  • Child
  • Encephalitis, Herpes Simplex (diagnosis, drug therapy)
  • Humans
  • Male
  • Polymerase Chain Reaction
  • Prodrugs
  • Valacyclovir
  • Valine (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: